Poseida Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid
Poseida Therapeutics, Inc. had Lessee, Operating Lease, Liability, to be Paid of $29.30 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2024-11-07
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid $29.30M.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid $30.86M.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid $32.41M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $33.93M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2024-09-30 | $29.30M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $30.86M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $32.41M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $33.93M 10-K · filed 2024-03-07 |
| 2023-09-30 | $35.45M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $36.96M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $38.46M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $40.02M 10-K · filed 2023-03-09 |
| 2022-09-30 | $42.72M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $44.44M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $46.91M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $43.44M 10-K · filed 2022-03-10 |
| 2021-10-31 | $5.20M 10-K · filed 2022-03-10 |
| 2021-09-30 | $42.57M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $44.15M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $45.73M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $43.76M 10-K · filed 2021-03-11 |
| 2020-09-30 | $43.96M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $37.36M 10-Q · filed 2020-08-20 |